Involvement of Thrombolysis in Recombinant Tissue Plasminogen Activator-Induced Cerebral Hemorrhages and Effect on Infarct Volume and Postischemic Endothelial Function
- 1 December 2003
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 34 (12), 2975-2979
- https://doi.org/10.1161/01.str.0000101914.62066.7b
Abstract
Background and Purpose— In a model of mechanical focal ischemia, we investigated the involvement of thrombolysis products (TLP) in recombinant tissue plasminogen activator (rtPA)-induced intracerebral complications and the effects on infarct volume and postischemic endothelial function. Methods— Hemorrhage incidence and severity were evaluated by histomorphometric analysis in male spontaneously hypertensive rats (SHR) subjected to 60-minute intraluminal middle cerebral artery (MCA) occlusion and receiving intravenously 5 hours later either saline, rtPA (3, 10, or 30 mg/kg), or rtPA (10 mg/kg) associated with TLP (rtPA+TLP). In addition, MCA reactivity was assessed in rtPA- or rtPA+TLP-treated SHR versus control Wistar-Kyoto rats or SHR. Results— No hemorrhage was observed visually in SHR receiving saline. In contrast, rtPA administration induced hemorrhagic complications in infarcted areas in a dose-independent manner. Administration of rtPA+TLP solution, containing a high concentration of plasmin, did not affect hemorrhage incidence but significantly increased hemorrhage severity (8.8±2.3 petechiae versus 3.0±1.0 petechiae in rtPA group; P 3 in rtPA group; P P Conclusions— Treatment with rtPA led to intracerebral hemorrhages, in contrast to saline-treated animals, and the presence of TLP increased the severity of these hemorrhages, in parallel with increased infarct volume and worsened endothelial function.Keywords
This publication has 20 references indexed in Scilit:
- Distinct dose-dependent effects of plasmin and TPA on coagulation and hemorrhageBlood, 2003
- Blood-Brain Barrier Disruption and Matrix Metalloproteinase-9 Expression During Reperfusion InjuryStroke, 2002
- Reducing Bleeding Complications After Thrombolytic Therapy for StrokeCNS Drugs, 2001
- Ischaemic preconditioning of the vasculature: an overlooked phenomenon for protecting the heart?Trends in Pharmacological Sciences, 2000
- Relationship between Inward Rectifier Potassium Current Impairment and Brain Injury after Cerebral Ischemia/ReperfusionJournal of Cerebral Blood Flow & Metabolism, 1999
- Neutral proteases and disruption of the blood–brain barrier in ratBrain Research, 1997
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Intravenous Thrombolysis With Recombinant Tissue Plasminogen Activator for Acute Hemispheric StrokeJAMA, 1995
- Effect of Delayed Thrombolysis with rt-PA in a Rat Embolic Stroke ModelJournal of Cerebral Blood Flow & Metabolism, 1994
- Increased serum levels of fibrinogen degradation products due to treatment with recombinant tissue-type plasminogen activator for acute myocardial infarction are related to bleeding complications, but not to coronary patencyJournal of the American College of Cardiology, 1989